Champions Oncology, Inc. (CSBR) — Analysis Summary
Champions Oncology, Inc. (CSBR) has a market cap of $81.03M with year-over-year revenue growth of +13.5%. Net margin stands at 8.3%. The stock trades at a P/E ratio of -34.6.
Key Takeaways
- Revenue changed +13.5% year-over-year
- Net margin of 8.3%
- P/E ratio of -34.6
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, CSBR posted revenue growth of +13.5% and trades at a P/E of -34.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.